Côte d'Ivoire vs Malta: Number of isolates tested for extended-spectrum cephalosporins
Côte d'Ivoire
30
in 2018
Malta
25
in 2018
Côte d'Ivoire rank
42nd
Malta rank
44th
Number of isolates tested for extended-spectrum cephalosporins over time
- Côte d'Ivoire
- Malta
How they compare
Côte d'Ivoire currently reports 30 against 25 in Malta, a difference of 5.
That makes Côte d'Ivoire's figure about 1.2 times Malta's.
The two have swapped places 1 time across 8 shared years of data; in 2009 it was Malta ahead.
Côte d'Ivoire ranks 42nd and Malta ranks 44th of 51 countries.
Across the 2 decades both report, Côte d'Ivoire averaged higher in 1 and Malta in 1.
Head to head by decade
| Decade | Côte d'Ivoire | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10 | 22 | 12 | Malta |
| 2010s | 44.43 | 26.71 | 17.71 | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for extended-spectrum cephalosporins, Côte d'Ivoire or Malta?
- Côte d'Ivoire, at 30 against 25 in Malta as of 2018.
- What is the difference in number of isolates tested for extended-spectrum cephalosporins between Côte d'Ivoire and Malta?
- 5, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Malta?
- 8 years are reported by both, from 2009 to 2018.
- How do Côte d'Ivoire and Malta rank globally for number of isolates tested for extended-spectrum cephalosporins?
- Côte d'Ivoire ranks 42nd and Malta ranks 44th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for extended-spectrum cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.